<p>Brookstone Capital Management 在最近向 SEC 提交的 13F 文件中表示，在第三季度将其在 Intuitive Surgical, Inc.（NASDAQ:ISRG - 免费报告）的持股增加了 48.7%。该公司在本季度购买了 12,014 股后，持有该医疗设备提供商的 36,707 股股票。Brookstone Capital Management 在 Intuitive Surgical 的持股在最近一个季度末的价值为 16,416,000 美元。</p>
<p>获取 <strong>Intuitive Surgical</strong> 提醒：</p>
<ul>
<li>1.34 亿美元的内部交易：这对 KMI、ISRG 和 QS 可能意味着什么</li>
</ul>
<p>其他对冲基金也买卖了该公司的股票。挪威银行在第二季度购买了价值约 25.69 亿美元的 Intuitive Surgical 新股份。先锋集团在第二季度将其在 Intuitive Surgical 的持股增加了 2.1%。先锋集团目前拥有 33,335,833 股该医疗设备提供商的股票，价值为 181.15 亿美元，此前在该期间内又购买了 670,302 股。瑞银资产管理的一个独立业务单位在第一季度将其在 Intuitive Surgical 的持股增加了 20.1%。瑞银资产管理的该独立业务单位目前拥有 3,393,951 股该医疗设备提供商的股票，价值为 16.81 亿美元，此前在该期间内又购买了 566,979 股。Jennison Associates LLC 在第二季度将其在 Intuitive Surgical 的持股增加了 20.4%。Jennison Associates LLC 目前拥有 3,122,390 股该医疗设备提供商的股票，价值为 16.97 亿美元，此前在上个季度又购买了 528,359 股。最后，贝斯默集团在第二季度将其在 Intuitive Surgical 的持股增加了 89.3%。贝斯默集团目前拥有 788,328 股该医疗设备提供商的股票，价值为 4.28386 亿美元，此前在该期间内又购买了 371,806 股。机构投资者持有该公司 83.64% 的股票。</p>
<h2>Intuitive Surgical 股票上涨 0.1%</h2>
<p>Intuitive Surgical 的股票在周四以 578.10 美元开盘。该公司的市值为 2072.4 亿美元，市盈率为 76.47，PEG 比率为 5.28，贝塔值为 1.68。该公司的 50 日移动平均价格为 550.03 美元，200 日移动平均价格为 506.41 美元。Intuitive Surgical, Inc.的 12 个月低点为 425.00 美元，12 个月高点为 616.00 美元。</p>
<ul>
<li>在特朗普关税政策下表现突出的前三只股票</li>
</ul>
<p>Intuitive Surgical（NASDAQ:ISRG - 获取免费报告）最近于 10 月 21 日（星期二）公布了季度财报。该医疗设备提供商报告本季度每股收益为 2.40 美元，超出分析师一致预期的 1.99 美元，超出幅度为 0.41 美元。Intuitive Surgical 的股本回报率为 15.08%，净利润率为 28.58%。该公司在本季度的收入为 25.1 亿美元，而分析师预期为 24.1 亿美元。在去年同期，该公司每股收益为 1.84 美元。该公司的收入同比增长 22.9%。平均而言，股票分析师预计 Intuitive Surgical, Inc.在当前财政年度将发布 6.43 美元的每股收益。</p>
<h2>内部活动</h2>
<p>在相关消息中，高级副总裁 Mark Brosius 于 12 月 12 日（星期五）出售了 4,500 股公司的股票。该股票以平均价格 547.36 美元出售，总价值为 2,463,120.00 美元。交易完成后，该高级副总裁直接持有 907 股公司的股票，价值约为 496,455.52 美元。此交易代表其持股减少了 83.23%。该交易已在向 SEC 提交的文件中披露，可以通过此超链接访问。此外，首席执行官 David J. Rosa 于 10 月 24 日（星期五）出售了 24,500 股公司的股票。该股票以平均价格 547.55 美元出售，总交易额为 13,414,975.00 美元。出售后，首席执行官直接持有 234,256 股公司的股票，价值约为 128,266,872.80 美元。该交易使其持股减少了 9.47%。该销售的 SEC 文件提供了更多信息。在过去的九十天里，内部人士出售了 114,007 股公司股票，价值为 63,533,844 美元。0.70% 的股票由公司内部人士持有。</p>
<h2>分析师评级变动</h2>
<ul>
<li>为什么 Intuitive Surgical 对长期投资者来说是个明智之选</li>
</ul>
<p>几位分析师最近对 ISRG 股票发表了评论。Evercore ISI 在 10 月 22 日（星期三）的研究报告中将 Intuitive Surgical 的目标价格从 450.00 美元上调至 540.00 美元。富国银行在 12 月 12 日（星期五）将 Intuitive Surgical 的目标价格从 600.00 美元上调至 654.00 美元，并给予该公司 “超配” 评级。Leerink Partners 在 10 月 22 日（星期三）的研究报告中将 Intuitive Surgical 的目标价格从 593.00 美元上调至 600.00 美元，并给予该公司 “跑赢大盘” 评级。大和资本市场在 10 月 24 日（星期五）将 Intuitive Surgical 的目标价格从 510.00 美元上调至 550.00 美元，并给予该股票 “跑赢大盘” 评级。最后，Argus 在 10 月 27 日（星期一）的研究报告中将 Intuitive Surgical 的目标价格从 600.00 美元上调至 630.00 美元。两位股票研究分析师对该股票给予 “强烈买入” 评级，十六位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价格为 611.08 美元。</p>
<p><strong>获取我们最新的 ISRG 研究报告</strong></p>
<h2>Intuitive Surgical 公司简介</h2>
<p>（免费报告）</p>
<p>直觉外科成立于 1995 年，总部位于加利福尼亚州的阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗科技公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉外科的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室内的精确度、可视化和控制能力。</p>
<p>除了核心手术平台外，直觉外科还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过直觉外科</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “$3 AI 奇迹股票” 即将腾飞</li>
<li>任何费用可以从资本利得税中扣除吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
<li>忘掉 AI 吧，这将是下一个重大科技突破</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在直觉外科吗？</h2>
<p>在考虑直觉外科之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
<p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

直觉外科

<p>Brookstone Capital Management 在第三季度将其在直觉外科公司的股份增加了 48.7%，目前持有 36,707 股，价值 1,642 万美元。其他对冲基金也增加了他们的持仓。直觉外科报告了强劲的第三季度财报，营收同比增长 22.9%。内部人士的活动包括高管的大量股票出售。分析师提高了对该股票的目标价</p>

<p>Brookstone Capital Management increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 48.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 36,707 shares of the medical equipment provider's stock after purchasing an additional 12,014 shares during the quarter. Brookstone Capital Management's holdings in Intuitive Surgical were worth $16,416,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Brookstone Capital Management 在最近向 SEC 提交的 13F 文件中表示，在第三季度将其在 Intuitive Surgical, Inc.（NASDAQ:ISRG - 免费报告）的持股增加了 48.7%。该公司在本季度购买了 12,014 股后，持有该医疗设备提供商的 36,707 股股票。Brookstone Capital Management 在 Intuitive Surgical 的持股在最近一个季度末的价值为 16,416,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Intuitive Surgical</strong> 提醒：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 亿美元的内部交易：这对 KMI、ISRG 和 QS 可能意味着什么</li>
</ul>
</div><p>Other hedge funds have also bought and sold shares of the company. Norges Bank purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $2,569,260,000. Vanguard Group Inc. raised its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock worth $18,115,025,000 after acquiring an additional 670,302 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the period. Jennison Associates LLC lifted its holdings in Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider's stock valued at $1,696,738,000 after purchasing an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. boosted its position in shares of Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider's stock worth $428,386,000 after purchasing an additional 371,806 shares during the period. Institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金也买卖了该公司的股票。挪威银行在第二季度购买了价值约 25.69 亿美元的 Intuitive Surgical 新股份。先锋集团在第二季度将其在 Intuitive Surgical 的持股增加了 2.1%。先锋集团目前拥有 33,335,833 股该医疗设备提供商的股票，价值为 181.15 亿美元，此前在该期间内又购买了 670,302 股。瑞银资产管理的一个独立业务单位在第一季度将其在 Intuitive Surgical 的持股增加了 20.1%。瑞银资产管理的该独立业务单位目前拥有 3,393,951 股该医疗设备提供商的股票，价值为 16.81 亿美元，此前在该期间内又购买了 566,979 股。Jennison Associates LLC 在第二季度将其在 Intuitive Surgical 的持股增加了 20.4%。Jennison Associates LLC 目前拥有 3,122,390 股该医疗设备提供商的股票，价值为 16.97 亿美元，此前在上个季度又购买了 528,359 股。最后，贝斯默集团在第二季度将其在 Intuitive Surgical 的持股增加了 89.3%。贝斯默集团目前拥有 788,328 股该医疗设备提供商的股票，价值为 4.28386 亿美元，此前在该期间内又购买了 371,806 股。机构投资者持有该公司 83.64% 的股票。</p>
</div><h2>Intuitive Surgical Stock Up 0.1%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股票上涨 0.1%</h2>
</div><p>Shares of Intuitive Surgical stock opened at $578.10 on Thursday. The firm has a market cap of $207.24 billion, a price-to-earnings ratio of 76.47, a PEG ratio of 5.28 and a beta of 1.68. The business has a 50-day moving average price of $550.03 and a 200-day moving average price of $506.41. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.</p>
<div class="lb-trans"><p>Intuitive Surgical 的股票在周四以 578.10 美元开盘。该公司的市值为 2072.4 亿美元，市盈率为 76.47，PEG 比率为 5.28，贝塔值为 1.68。该公司的 50 日移动平均价格为 550.03 美元，200 日移动平均价格为 506.41 美元。Intuitive Surgical, Inc.的 12 个月低点为 425.00 美元，12 个月高点为 616.00 美元。</p>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>在特朗普关税政策下表现突出的前三只股票</li>
</ul>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts' consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the company earned $1.84 earnings per share. The firm's revenue was up 22.9% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Intuitive Surgical（NASDAQ:ISRG - 获取免费报告）最近于 10 月 21 日（星期二）公布了季度财报。该医疗设备提供商报告本季度每股收益为 2.40 美元，超出分析师一致预期的 1.99 美元，超出幅度为 0.41 美元。Intuitive Surgical 的股本回报率为 15.08%，净利润率为 28.58%。该公司在本季度的收入为 25.1 亿美元，而分析师预期为 24.1 亿美元。在去年同期，该公司每股收益为 1.84 美元。该公司的收入同比增长 22.9%。平均而言，股票分析师预计 Intuitive Surgical, Inc.在当前财政年度将发布 6.43 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In related news, SVP Mark Brosius sold 4,500 shares of the firm's stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the company's stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，高级副总裁 Mark Brosius 于 12 月 12 日（星期五）出售了 4,500 股公司的股票。该股票以平均价格 547.36 美元出售，总价值为 2,463,120.00 美元。交易完成后，该高级副总裁直接持有 907 股公司的股票，价值约为 496,455.52 美元。此交易代表其持股减少了 83.23%。该交易已在向 SEC 提交的文件中披露，可以通过此超链接访问。此外，首席执行官 David J. Rosa 于 10 月 24 日（星期五）出售了 24,500 股公司的股票。该股票以平均价格 547.55 美元出售，总交易额为 13,414,975.00 美元。出售后，首席执行官直接持有 234,256 股公司的股票，价值约为 128,266,872.80 美元。该交易使其持股减少了 9.47%。该销售的 SEC 文件提供了更多信息。在过去的九十天里，内部人士出售了 114,007 股公司股票，价值为 63,533,844 美元。0.70% 的股票由公司内部人士持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Intuitive Surgical 对长期投资者来说是个明智之选</li>
</ul>
</div><p>Several analysts have recently commented on ISRG shares. Evercore ISI raised their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Wells Fargo &amp; Company raised their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, December 12th. Leerink Partners boosted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an &#34;outperform&#34; rating in a research report on Wednesday, October 22nd. Daiwa Capital Markets increased their target price on Intuitive Surgical from $510.00 to $550.00 and gave the stock an &#34;outperform&#34; rating in a research report on Friday, October 24th. Finally, Argus lifted their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $611.08.</p>
<div class="lb-trans"><p>几位分析师最近对 ISRG 股票发表了评论。Evercore ISI 在 10 月 22 日（星期三）的研究报告中将 Intuitive Surgical 的目标价格从 450.00 美元上调至 540.00 美元。富国银行在 12 月 12 日（星期五）将 Intuitive Surgical 的目标价格从 600.00 美元上调至 654.00 美元，并给予该公司 “超配” 评级。Leerink Partners 在 10 月 22 日（星期三）的研究报告中将 Intuitive Surgical 的目标价格从 593.00 美元上调至 600.00 美元，并给予该公司 “跑赢大盘” 评级。大和资本市场在 10 月 24 日（星期五）将 Intuitive Surgical 的目标价格从 510.00 美元上调至 550.00 美元，并给予该股票 “跑赢大盘” 评级。最后，Argus 在 10 月 27 日（星期一）的研究报告中将 Intuitive Surgical 的目标价格从 600.00 美元上调至 630.00 美元。两位股票研究分析师对该股票给予 “强烈买入” 评级，十六位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价格为 611.08 美元。</p>
</div><p><strong>Get Our Latest Research Report on ISRG</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 ISRG 研究报告</strong></p>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>Intuitive Surgical 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直觉外科成立于 1995 年，总部位于加利福尼亚州的阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗科技公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉外科的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室内的精确度、可视化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手术平台外，直觉外科还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>Forget AI, This Will Be the Next Big Tech Breakthrough</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过直觉外科</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “$3 AI 奇迹股票” 即将腾飞</li>
<li>任何费用可以从资本利得税中扣除吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
<li>忘掉 AI 吧，这将是下一个重大科技突破</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在直觉外科吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑直觉外科之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Brookstone 资本管理公司增持了直觉外科公司（Intuitive Surgical, Inc.），股票代码为$ISRG